Why the study?
The specific browning factors that improve glucose uptake beyond normal levels remain unknown, although glucose uptake is not affected in UCP1 knockout mice.
Does elevating UCP1 levels improve glucose uptake in human white adipocytes?
Does elevating UCP1 levels improve glucose uptake in human white adipocytes?
Elevating UCP1 levels in human white adipocytes is sufficient to improve glucose uptake by 40% via increased glycolytic flux, suggesting a potential therapeutic target for metabolic health without requiring complex browning networks.
Hypothesis-generating for UCP1-targeted metabolic therapies; leaves open translation to human adipocytes and clinical outcomes.
Brown adipose tissue (BAT) has been considered beneficial for metabolic health by participating in the regulation of glucose homoeostasis. The browning factors that improve glucose uptake beyond normal levels are still unknown but glucose uptake is not affected in UCP1 knockout mice. Here, we demonstrate in human white adipocytes that basal/resting glucose uptake is improved by solely elevating UCP1 protein levels. Generating human white Simpson-Golabi-Behmel syndrome (SGBS) adipocytes with a stable knockout and overexpression of UCP1, we discovered that UCP1 overexpressing adipocytes significantly improve glucose uptake by 40%. Mechanistically, this is caused by higher glycolytic flux, seen as increased oxygen consumption, extracellular acidification and lactate secretion rates. The improvements in glucose handling are comparable to white-to-brown transitions, as judged by, for the first time, directly comparing in vitro differentiated mouse brown vs white adipocytes. Although no adipogenic, metabolic and mitochondrial gene expressions were significantly altered in SGBS cells, pharmacological inhibition of GLUT1 completely abrogated differences between UCP1+ and control cells, thereby uncovering GLUT1-mediated uptake as permissive gatekeeper. Collectively, our data demonstrate that elevating UCP1 levels is sufficient to improve human white adipocytes as a glucose sink without adverse cellular effects, thus not requiring the adrenergic controlled, complex network of browning which usually hampers translational efforts.
No takes yet. Share an insight, caveat, or question.
Tews et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: